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Abstract 
Background: There is a lack of scientific evidence on how socioeconomically disadvantaged tobacco users can be 
reached with tobacco cessation interventions in Swedish primary healthcare (PHC). In this setting other lifestyle inter-
ventions are available by prescription, and there is the potential to develop a similar tool for tobacco cessation. The 
aim of this study was thus to explore the perceived feasibility and optimal design of Tobacco Cessation on Prescrip-
tion (TCP) in PHC, targeting disadvantaged groups in Sweden.
Methods: This qualitative study is based on semi-structured interviews with 32 participants including (1) three 
experts in lifestyle interventions on prescription, (2) 14 healthcare providers and (3) 15 clients from three PHC cen-
tres in socioeconomically disadvantaged areas in Stockholm where tobacco use is high. The interviews were audio-
recorded and transcribed verbatim. The manifest content of the transcripts was analysed according to a modified 
conventional approach to content analysis.
Results: The interviewees proposed that TCP should include a template comprising the client’s information, evi-
dence-based tobacco cessation options and choices for follow-up. They also suggested including information about 
the benefits of tobacco cessation, as well as empowerment and planning support tools. The participants also com-
mented that other measures for tobacco cessation could be included on the prescription. From the clients’ point of 
view, the perceived advantages of TCP were often linked to an emotional meaning (e.g. increased motivation to quit 
tobacco use, sign of support from the healthcare system to seek care for tobacco cessation). For providers, advantages 
with TCP were frequently related to a practical meaning (e.g. improved documentation and facilitation of tobacco ces-
sation treatment). The disadvantages identified were mainly connected with the future implementation of TCP (e.g. 
low self-efficacy among clients and providers).
Conclusions: TCP was perceived to be a useful tool for both clients and providers, potentially facilitating a structured 
and effective approach to tobacco cessation in PHC, and targeting disadvantaged groups. More research is needed 
to develop the prescription and investigate its effectiveness and cost-effectiveness compared to current strategies for 
tobacco cessation in a PHC setting.
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Background
Tobacco use is the leading preventable cause of death 
worldwide [1], estimated to cause approximately 10 % of 
all premature deaths in Sweden [2]. Furthermore, chronic 
illnesses caused by tobacco use remain a public health 
problem in Sweden—particularly in socioeconomically 
disadvantaged groups, where tobacco use is markedly 
higher than in the general population [3]. Since tobacco 
cessation has been found to reduce the risk of tobacco 
related morbidity and mortality [4], it is a prioritised tar-
get area in Swedish public health policy [5]. How tobacco 
cessation should be tackled is described in the National 
Board of Health and Welfare’s guidelines for disease pre-
vention methods [6]. Recommended treatment options 
include different types of counselling (simple advice, 
counselling, qualified advice, web- and computer-based 
counselling and proactive telephone counselling) with or 
without pharmacotherapy (nicotine replacement therapy, 
varenicline and bupropion) [6]. However, these types of 
health-promoting interventions often fail to reach those 
in greatest need [6]. Difficulties in reaching disadvan-
taged groups with tobacco cessation interventions could 
be explained by a lack of motivation, low self-efficacy, 
reduced social support for quitting and understanding of 
the harmful effects of tobacco use, a stronger addiction to 
tobacco, targeted marketing by the tobacco industry and 
low adherence to treatment [7]. In addition, the costs of 
pharmacotherapy and counselling present particular bar-
riers for disadvantaged tobacco users to seek and com-
plete treatment for tobacco cessation [8, 9].
Studies conducted in Stockholm on healthcare con-
sumption in different social settings show that individuals 
with low socioeconomic status and foreign origin often 
visit primary healthcare (PHC) [10]. PHC may therefore 
be seen as a potential platform for reaching disadvan-
taged groups with health-promoting activities. Although 
the utilisation of PHC is on a par with other groups of 
the population, the proportion of medical needs not met 
is higher among disadvantaged groups who frequently 
feel discriminated against by the healthcare system [10]. 
Among PHC staff, there is a need for more knowledge 
and training in how to work with disadvantaged groups 
for efficient health promotion [11, 12]. There is also a 
need for healthcare programmes, routines and documen-
tation tools to facilitate such efforts [13].
Physical activity on prescription (PAP) is a lifestyle 
intervention on prescription, which has been successfully 
tested and validated in the general population in Sweden 
[14, 15]. Methods to prescribe physical activity have also 
been applied in the healthcare systems in Norway, Den-
mark, Finland, Great Britain, New Zealand, Australia, 
USA and Spain [16–22]. In Sweden, PAP is adhered to 
in a way comparable to medical treatments of chronic 
diseases and has been found to lead to increased physi-
cal activity levels and improved health and quality of life 
[15]. Previous research suggests that there is a demand 
among tobacco users in Sweden for receiving tobacco 
cessation support from healthcare providers [13], e.g. 
through referrals [23]. Therefore, Tobacco Cessation on 
Prescription (TCP) has the potential to become a com-
prehensive, health-promoting tool in the Swedish PHC 
setting. TCP may also increase the willingness amongst 
clients to receive assistance, as tobacco cessation would 
obtain a status like other medical care [24]. A prescrip-
tion approach to tobacco cessation treatment could also 
be relevant in other countries where prescriptions to pro-
mote lifestyle changes are already in use. This study aims 
to explore the perceived feasibility and optimal design 
of TCP as an innovative and complementary tool for 
tobacco cessation in PHC, targeting socioeconomically 
disadvantaged groups in Sweden.
Methods
Recruitment and sample selection
An exploratory study design, based on semi-structured 
interviews, was adopted to gather an in-depth under-
standing of the informants’ views on TCP and related 
issues. This approach was chosen since it is recommended 
when there is little knowledge about the subject of inter-
est [25]. Experts in lifestyle interventions on prescription, 
adult tobacco users and PHC providers were purposively 
sampled [26] and invited to participate. Purposive sam-
pling was applied since it is recommended in qualitative 
studies where the researchers are interested in interview-
ing those with the best knowledge concerning the sub-
ject of interest [27]. Experts were identified through their 
involvement in previous research projects conducted in 
Sweden on lifestyle interventions by prescription and 
were recruited to participate by the researchers. Clients 
and providers were recruited from three PHC centres 
situated in socioeconomically disadvantaged areas in 
Stockholm. The areas were identified through a socioeco-
nomic index [28] that is used by the Stockholm County 
Council to follow up resource allocation in PHC and 
takes into account the income, educational level, health 
status and ethnicity of the population living in the area. 
Providers were licenced medical professionals who were 
identified and recruited by the researchers; clients were 
identified and recruited by the PHC staff. Eligible clients 
were self-reported tobacco users over 18 years of age who 
visited the PHC centres that were involved in the study. 
As an incentive, the participants received a 100 SEK gift 
card for partaking in the study. Of the approximately 
50 participants that were invited to participate, 32 were 
interviewed, of which three were experts, 15 were clients 
and 14 were providers. Further details on the participant 
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characteristics are presented in Table 1. Most non-partic-
ipants were clients, representing different sexes and ages. 
Reported reasons for non-participation were lack of time 
and interest.
Data collection
Data was collected between February and May 2014 
through semi-structured interviews in conversational 
form, based on interview guides with open-ended ques-
tions, developed specifically for each respondent cat-
egory (Appendices 1, 2, 3). Clients and providers were 
asked about their tobacco use, experiences of tobacco 
cessation and opinions on the concept of, and requested 
content on, TCP. It was described as a prescription form 
similar to prescriptions of pharmaceuticals and physi-
cal activity, which could be administered by a healthcare 
provider to a client in the PHC setting to support and 
facilitate tobacco cessation. The participating experts, 
providers and clients were all previously familiar with 
prescriptions of pharmaceuticals. All of the experts and 
providers, and most of the clients, were also previously 
familiar with PAP. Clients were asked about their health. 
Experts were asked about lessons learned from other life-
style interventions on prescription, the possibilities and 
barriers associated with these interventions, and how 
they might impact upon TCP. Examples of interview 
questions related to the aim of the study were: “If you 
could prescribe/get a prescription for tobacco cessation, 
what would you think about that?” and “What are the 
possible advantages and disadvantages of TCP?”
Twenty-eight of the interviews were conducted face-to-
face, while two of the expert interviews and two of the 
client interviews were conducted via telephone based 
on participant preference. The face-to-face interviews 
were conducted in private rooms, located in the PHC 
centres where the participants were recruited. Due to 
specific requests from participants, one client interview 
was conducted in the waiting room and one provider 
interview was conducted in the interviewer’s office. On 
average, the interviews lasted for approximately 30 min. 
All interviews were conducted by an experienced inter-
viewer with degrees in health communication and global 
health science. All but one of the interviews were con-
ducted in Swedish. The exception was carried out in Ara-
bic in collaboration with a translator. All interviews were 
audio-recorded and supplemented with field notes. The 
interviewer transcribed each interview verbatim. A pro-
fessional agency transcribed and translated the interview 
from Arabic to Swedish.
Data analysis
Data was collected until a point in time at which the anal-
ysis provided no more emergent patterns [29]. The final 
analysis was based on a conventional approach to con-
tent analysis [30]. The chosen approach was considered 
appropriate since it is recommended in studies when 
existing theory or research literature on the phenomenon 
that is being explored is limited [30]. In order to obtain 
an overview of data, the transcripts were read several 
times by two members of the research team. The tran-
scribed text on TCP related issues was extracted from the 
responses of all three categories of respondents and was 
brought together to constitute the unit of analysis. The 
responses from all participants were analysed together 
to value each respondent category’s opinions equally and 
to get an overview of the overall opinions on TCP from 
all included stakeholders. However, their accounts are 
reported separately in the results to highlight similari-
ties and differences between the responses from differ-
ent categories. Meaning units were identified, abstracted 
inductively and labelled with codes after analysing the 
text word by word. Based upon the manifest content of 
the text and differences and similarities between the 
codes, these were combined into thirteen sub-categories 
and four categories. With the exception of condensing 
meaning units and formulating themes, the analysis was 
conducted as described by Graneheim and Lundman 
[31]. The identified codes, sub-categories and categories 
are presented in Table 2. The software QSR NVivo 10 was 
used in the coding process. The credibility of the analy-
sis was enhanced by random checks of the analysis, per-
formed by another member of the research team and an 
independent researcher experienced in qualitative meth-
ods but not part of the research team. The interrater reli-
ability was not formally measured but was perceived to 
be high by the coders. Contradicting opinions between 
the coders were discussed until a final categorisation of 
the codes was agreed upon. Results of the analysis were 
also checked for credibility of interpretation with three 
Table 1 Participant characteristics
Characteristic Total N (%) Respondent category
Client Provider Expert
% (n = 15) % (n = 14) % (n = 3)
Age
 18–29 2 (6) 7 7 0
 30–39 4 (13) 13 14 0
 40–49 9 (28) 27 21.5 67
 50–59 9 (28) 33 21.5 33
 60–69 8 (25) 20 36 0
Sex
 Female 20 (62.5) 40 93 33
 Male 12 (37.5) 60 7 67
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providers and two clients. Selected quotations are pre-
sented to reflect common answers from the respondents. 
Differences in responses are also highlighted.
Ethics
Ethical approval was obtained from the Regional Ethical 
Review Board in Stockholm in the autumn of 2013 [no: 
2013/2264-32/2]. Written informed consent was obtained 
from the participants before the start of each face-to-
face interview and verbal informed consent was obtained 
before the start of each telephone interview. The anonym-
ity and confidentiality of the participants was ensured by 
coding the participants as numbers (1–32) and removing 
all identifiers but the respondent category in the presen-
tation of the results. Furthermore, best practice guidelines 




Regarding the content of the prescription, providers sug-
gested that TCP could include information about the 
client’s diagnosis and contact person at the local PHC 
centre, as well as the type and time of follow-up. Fur-
thermore, both providers and clients stated that TCP 
could contain a list of different evidence-based cessation 
options, such as medications (varenicline, bupropion), 
aids (e.g. nicotine patches or gum replacement therapy), 
and physical activity/PAP.
“There should be different aids […] and pharma-
ceuticals [to choose from] on the prescription itself.” 
(Provider 18).
“There has to be a pre-printed list of options [for 
tobacco cessation] that there are to get help from […] 
so that one can check [a box] and write maybe freely 
the treatment plan and how one plans to follow it 
up.” (Provider 7).
Moreover, presenting alternatives for counselling on 
the TCP was suggested, e.g. via telephone or by referral to 
the Swedish quitline. Referrals to support groups, tobacco 
cessation courses and other relevant units or lifestyle clin-
ics were also mentioned. Information about the health 
benefits of tobacco cessation and cessation planning sup-
port, e.g. a reduction scheme or an action plan, were also 
requested by providers to be part of the prescription. 
Additionally, providers depicted TCP as comprising a list 
of empowerment options. For example, some providers 
described a “reward system”, allowing clients to reward 
themselves after not having used tobacco for a certain 
amount of time, or after having saved a certain amount of 
money by no longer purchasing tobacco products.
“I usually suggest [the client] going on a trip, to have 
a goal, or that they can go out and enjoy a good meal 
[as a reward for tobacco cessation].” (Provider 12).
Clients, providers and experts also suggested other 
non-evidence based cessation support ideas, such as 
relaxation, laser therapy, eating fruit, drinking water, 
engaging in cultural, outdoor and other “fun” activities, 
holidays, church visits, use of self-help books and e-ciga-
rettes to be included on the prescription.
“I think it’s good to have some kind of physical activ-
ity [on the prescription] but also to have some kind 
Table 2 Identified codes, sub-categories and categories
a From a client’s perspective “Perceptions of others” refer to perceptions of family members, friends and society. From a provider’s perspective it refers to perceptions 
of patients and colleagues
Code Sub-category Category
Cessation activity, general content, empowerment, contact, medical content, planning support, referral Content The prescription
Mode of administration, layout Design
Prescription for all smokers, prescription for those with a health problem, prescription for those with high 
self-efficacy
Target group Usage
Prescription whenever, prescription as soon as possible, prescription at a certain point in time When to receive TCP
No follow-up, when to follow-up, how to follow-up, why follow-up Follow-up
Shared responsibility, manager responsibility, occupational group responsibility Responsibility
Guideline characteristics, guideline content Guidelines
Positive emotional meaning, positive practical meaning, positive characteristics Advantages Expected results
Negative emotional meaning, negative practical meaning Disadvantages
Providers’ self-efficacy, clients’ self-efficacy Adherence
Others indifferent, others positive, others negative, others ambiguous Perceptions of othersa
Implementation prerequisites, person-centeredness, TCP as a package Implementation Feasibility
Motivation and competence, budget, organisational obstacles, infrastructure, time, capacity building Organisational aspects
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of relaxation [technique] […] like mindfulness or 
medical yoga that ensures that you relax […] and 
explain that ‘You are going to experience abstinence 
but if you hold out [relax] for a while it will also dis-
appear´.” (Expert 31).
Design
Some providers compared the design of TCP with that 
of PAP. Furthermore, the prescription was suggested to 
look “visually nice”. Most providers and clients described 
TCP as a paper prescription, as opposed to an electronic 
prescription.
“[TCP should be] like a real [paper] prescription. 
Anything else would be worthless because then you 
wouldn’t feel the same dignity as you feel with a doc-
tor.” (Provider 10).
“Nowadays, all prescriptions for medications are 
electronic […]. But at the same time it would be 
weird if you had an e-prescription if it was not for 
medications, if it was an e-prescription for some 
kind of activity one should do.” (Client 21).
Usage
Target group
Six of the providers stated that they would prescribe TCP 
to all tobacco users and nine of the providers stated that 
they would mainly prescribe it to tobacco users with 
smoking-related health problems like asthma/COPD, 
cardiovascular diseases, diabetes, high blood pressure, 
high cholesterol or allergies.
“I don’t think anyone should smoke! But those with 
diabetes, cardiovascular problems, asthma/COPD are 
the largest [target] groups [for TCP]. But again, it can 
be [prescribed] to all [tobacco users].” (Provider 4).
When to receive TCP
Clients frequently responded that they would like to be 
prescribed TCP “whenever”, “as soon as possible”, or at 
a certain point in time, e.g. once health status worsens, 
improves, or once the decision to quit tobacco use has 
been made.
Follow‑up
Providers considered a follow-up of the prescription as 
important. It was also considered significant for clients 
to keep track, be controlled, see progress, get motiva-
tion and find alternative solutions in case the prescribed 
cessation option did not work. However, some clients 
wished not to be followed up.
“I think it [follow-up] is needed. So that they [pro-
viders] hear how it went […]. That is always the best. 
[To] keep track.” (Client 14).
The clients suggested different time intervals for the 
follow-up; weekly, monthly, continuously, or sporadically.
“Maybe in the beginning [the client could be fol-
lowed-up] each week, if possible […] and later a bit 
more sporadically.” (Client 20).
It was suggested by two clients and two providers that 
the follow-up could be carried out via telephone. One 
provider commented that the follow-up by telephone 
could be done by a physician while another provider pro-
posed that it could be done by the Swedish quitline. In 
addition to the cessation progress and how TCP worked, 
it was suggested by a client that certain body functions 
could also be tested during the follow-up.
Responsibility
Providers suggested different ways of distributing the 
responsibility for TCP and its implementation—from 
being a shared responsibility between “everyone”, to being 
an exclusive responsibility of managers and specific occu-
pational groups, such as physicians, nurses, occupational 
therapists, physiotherapists, dieticians or specific units 
like asthma/COPD clinics.
“I think [it should be] like with PAP, that all nurses, 
all doctors, all [healthcare providers] who have con-
tact with the patient, can offer [TCP], except for 
pharmaceuticals–that is the doctors responsibility 
[…] I don’t think it [prescription of TCP] should be 
restricted to a certain [occupational] category. Then 
the usage would be lower.” (Provider 18).
Guidelines
Several providers requested guidelines for the prescrip-
tion of TCP, including information about recommended 
treatment and dosage alternatives and practical steps for 
healthcare providers to take in order to best support their 
clients in quitting their tobacco use.
“There could be some kind of [recommended] chain 
[of events, like] ´Write a prescription´, ´Inform […] 
about what happens when you smoke´, ´Inform 
about the Swedish quitline´ in different steps and if 
that’s not enough´ Refer to a lifestyle clinic’ as the 
next step.” (Provider 3).
Moreover, the providers expressed that the guidelines 
should be easy to use, permissive, generous, structured, 
and adaptable, without judgement and encouraging the 
provider to always take up the issue of tobacco use.
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Expected results
Advantages
TCP was often related to a positive emotional meaning 
for the clients. Participants from all three respondent 
categories expressed that TCP could give the client moti-
vation or help with cessation, and serve as a proof/con-
firmation for the seriousness of tobacco use as a health 
threat. In addition, some clients and providers perceived 
TCP as an opportunity, a positive pressure, a first step, 
a reminder, an inspiration and a guarantee for successful 
cessation.
“If one gets a’push’, a bit of support, then it would make 
it easier, at least for me [to quit smoking]. […] I would 
have made up my mind, after having talked to another 
person about this [tobacco cessation] and gotten a 
medication [on prescription]. Then I have to put the 
work in, make sure that it happens”. (Client 20).
In contrast to clients, providers often linked the advan-
tages of TCP to a practical meaning. TCP was seen as 
a useful tool in the daily routine and the follow-up of 
tobacco cessation treatment. It was also seen as an advan-
tage that all healthcare personnel would follow the same 
scheme in tobacco cessation. Providers considered TCP 
as being valuable for documentation, planning purposes, 
data collection and as an information source.
“It [tobacco cessation] becomes clearer with this 
method [TCP] and then patients can choose them-
selves which method they want to choose […] – it 
becomes much easier for healthcare personnel.” (Pro-
vider 18).
Providers often described TCP’s character as concrete, 
“official” and structured. In addition, TCP was seen as a 
tool for both clients and providers. Several clients and 
providers contended that the existence of TCP would 
show support from the health system and the healthcare 
staff in tobacco cessation.
“And he [the patient] can say ‘Look, I got a pre-
scription because the healthcare system says that I 
should stop smoking’, then they [the patients] can get 
motivation from their [family/friends], ‘God, he got 
a prescription. Now he shouldn’t smoke’ or ‘[…] it is 
serious, so now we must make sure that he does that 
[stop his tobacco use]’.” (Provider 8).
“Then [with TCP] I know that I have the right to seek 
[care for tobacco cessation].” (Client 20).
Disadvantages
Disadvantages of TCP were frequently related to an emo-
tional meaning for the participants. For instance, a lack 
of self-efficacy was seen as a disadvantage by some of the 
clients.
“The disadvantage would be that I’m not strong 
enough to accomplish that [tobacco cessation with 
TCP].” (Client 20).
Furthermore, some providers perceived TCP as poten-
tially pressuring the client in a negative way, or prescrip-
tion of TCP as a “stressful”, “humiliating” or “ridiculous” 
experience.
“He [the client] is allowed to buy Nicotine Replace-
ment Therapies (NRTs) […] without having this 
paper [TCP] in his hands. That [getting a prescrip-
tion for tobacco cessation] I can imagine some might 
think is a little humiliating”. (Provider 5).
In terms of practical meaning, providers related disad-
vantages of TCP to the risk of “prescribing wrongly” (i.e. 
prescribing something that would not help the client to 
quit) and scepticism towards TCP’s accessibility lan-
guage-wise for clients with insufficient Swedish language 
skills. Another disadvantage perceived by providers, was 
“the risk that TCP would be like PAP” in a negative way, 
i.e. “complicated” in terms of finding appropriate insti-
tutions to refer the client to, and “tricky” when it comes 
to forms and how to fill them out. Other disadvantages 
mentioned by providers related to insecurities about 
TCP’s content, lack of evidence for the prescription 
approach, potential technical problems with integrating 
the prescription into the electronic medical record, and a 
perceived lack of time and human resources for prescrib-
ing TCP.
“There is the disadvantage of having ‘one additional 
thing’ [to do].” (Provider 18).
The risk of forgetting, or not following up TCP, was 
also mentioned as a disadvantage. Some clients were 
insecure about TCP and some providers found it unnec-
essary, or perceived it as a way of “labelling smoking as a 
disease”.
Adherence
Experts and providers expected the adherence to TCP 
to be lower among healthcare providers and clients with 
low levels of self-efficacy. None of the clients discussed 
adherence during their interviews.
“I think it [the adherence to TCP] would be the same 
as with all other tobacco cessation [interventions]. I 
think it is more about motivating them [the clients]. 
Maybe the prescription could get them more moti-
vated and then the adherence would be higher.” (Pro-
vider 11).
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Perceptions of others
Clients and providers anticipated others not to care about 
TCP, being unsure (surprised or sceptical), perceiving it 
negatively (against TCP, frustrated, afraid of tobacco ces-
sation), positively or “worth trying”.
“I think that there are both, some who will perceive 




In order to facilitate the implementation of TCP, some 
providers suggested that it would be beneficial if TCP 
was designed as a “package”, linked to the electronic 
medical record, counselling and additional information. 
It was also considered important that the prescription 
was adaptable to the individual—even language-wise. 
One provider mentioned that a link between TCP and 
relevant collaborators could be beneficial. In order for 
TCP to be successful, some experts, clients and provid-
ers considered it necessary for the provider to ask the cli-
ent how he/she would like to go about tobacco cessation, 
which goals the client would have in terms of cessation 
and what the client would like to do to compensate for 
his/her tobacco use, before deciding together which of 
the available cessation options to choose. It was seen as 
a tool that could promote shared decision making and to 
more actively involve the client in the choice of cessation 
treatment.
“If I decide that’Ah, this [cessation option] suits you’, 
the patient won’t buy it. If you have it [the cessation 
options] on the prescription, then you can go through 
[them] with the patient. ‘This is a nicotine patch. 
Have you tried? Or what do you think, is gum better 
for you?’ Then you could tick [choose] the [type of ] 
aid together.” (Provider 18).
Other mentioned prerequisites for a successful imple-
mentation were that TCP should be simple, structured, 
easily accessible and usable.
“The prescription has to be found in Take Care [the 
electronic medical record] or the data system […] so 
that I can pick it up easily. It [the form] must be very 
easily filled in.” (Provider 18).
Organisational aspects
From the provider’s points of view, TCP was suggested to 
require motivation and competence from the healthcare 
personnel, but also an apposite budget, infrastructure and 
teamwork. Time was mentioned as an important factor. 
Some providers described a lack of time for prescribing 
TCP, while others could imagine implementing TCP in 
their daily routine. Some providers also stated that the 
County Council (healthcare system owner and main pro-
vider) would be responsible for allowing more time for 
prescribing TCP.
“As it is now […] we wouldn’t have time [to prescribe 
TCP] because we [healthcare providers] don’t have 
enough expertise and it [TCP] requires a lot more. 
You don’t just give them the note [prescription], so to 
speak.” (Provider 2).
Some experts and providers perceived difficulties 
reaching the intended target group. Moreover, some pro-
viders perceived a lack of evidence concerning the pre-
scription approach. Some providers also found it difficult 
to introduce new methods in PHC. Experts and provid-
ers stated that it would be beneficial if clients as well as 
providers received an economic advantage from using 
TCP. Some clients also expected an economic benefit for 
receiving TCP.
“‘On prescription’, then it [the treatment] should be 
included in the reimbursement scheme. Otherwise 
it [tobacco cessation treatment] is pretty expensive 
stuff, I have heard.” (Client 22).
Furthermore, a good introduction to TCP for health-
care personnel was found important and expected to 
have a positive effect on its uptake.
Discussion
Overall, the concept of TCP was considered a valu-
able support for both providers and clients, facilitat-
ing tobacco cessation treatment among disadvantaged 
groups in PHC in a new, easy and structured way. The 
prescription, containing an overview of available ces-
sation options and planning support, could serve as an 
information source, but also as a basis for discussion 
between the provider and the client. TCP would allow 
each client to—together with their caregiver—choose 
the cessation options that suit them the best, tailoring 
the prescription to meet their individual preferences and 
needs. Previous research suggests that personalised and 
non-judgemental approaches [8] that combine behav-
ioural support and pharmacotherapy are effective in sup-
porting and engaging disadvantaged tobacco users to 
quit [33].
The importance of offering and combining a variety 
of treatment options in tobacco cessation became clear 
in the study, since several participants were sceptical 
towards the use of pharmaceuticals but positive towards 
some non-traditional measures for tobacco cessation. A 
recent clinical review suggests that some of the methods 
mentioned by the participants (e.g. relaxation techniques, 
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drinking water, eating low fat foods like fruit and engag-
ing in physical, fun and health promoting activities) may 
be used as strategies for stress management or distrac-
tion to reduce cravings and withdrawal symptoms [34]. 
Although these options are unlikely to be pre-printed on 
the prescription, these could beneficially be discussed in 
relation to the prescription of TCP. If the client shows 
interest in a non-evidence based and potentially harm-
ful option in these discussions, such as e-cigarettes, this 
should not be promoted. Self-efficacy could be improved 
by involving clients in the choice of treatment and by 
providing empowerment and planning support on the 
prescription. The importance of self-efficacy in tobacco 
cessation has previously been highlighted in the litera-
ture [35–37]. It was also considered the most influential 
determinant of successful cessation among providers and 
clients in the study.
Although this was not the focus of the study, a need 
for increased awareness about available cessation alter-
natives emerged, since few of the participants seemed 
to know about the services available to help them. Simi-
lar findings have been presented in previous research, 
which also suggests that there are misconceptions in 
this population about the availability and effectiveness 
of such services [8]. In order to reach disadvantaged 
groups with tobacco cessation interventions it is recom-
mended that free or heavily subsidised NRTs should be 
offered and that targeted marketing strategies using mass 
media should be applied [38]. Currently, neither of these 
strategies are used in Sweden. Although the long term 
effects of these strategies have not been established [33, 
39–41], informing the target group about TCP including 
its potential financial benefits could increase the demand 
and utilisation of NRTs and other tobacco cessation treat-
ments among disadvantaged tobacco users in PHC in 
Sweden. The fact that economic incentives influence an 
individual’s willingness to participate in other life style 
intervention on prescription programmes support this 
statement [42].
Perceived challenges with the implementation of TCP 
were related to a lack of time, resources and knowledge 
to prescribe TCP. The same obstacles and the need 
for education, routines and guidelines have previously 
been stressed by primary care providers in relation to 
physical activity counselling [43] and prescriptions 
[44]. Development of guidelines and education of PHC 
staff in how to prescribe TCP should therefore be con-
sidered crucial in the implementation process. Since 
the lack of reimbursement for preventive counselling 
is also considered a major barrier [43], financial incen-
tives may be needed to motivate PHC staff to prescribe 
TCP. Previous research suggests that financial incen-
tives enhance the likelihood that PHC will devote time 
to health promotion [45]. Without financial support, 
there is a risk that other activities that are reimbursed 
will be prioritised [46]. Despite these challenges, the 
prescription approach has previously been found effec-
tive in changing lifestyle behaviour when clear advice 
was given and prescribed with the same conviction as 
a drug [15]. Studies have shown that PAP increases 
self-efficacy [47] and physical activity, while decreas-
ing the proportion of inactive individuals and reduc-
ing costs for inactivity by 22  % [48]. The adherence 
to PAP has further been found to be similar to that of 
other treatments for chronic diseases [15]. Although 
the adherence to prescribed medications is generally 
lower in disadvantaged groups [8], the study partici-
pants reported that they would become motivated by 
receiving a prescription on tobacco cessation. Most of 
the participants also stated that they had high levels 
of trust in their caregivers and considered TCP to be a 
demonstration of support from the healthcare system. 
Since a client’s trust in the provider and the healthcare 
system has a positive effect on adherence to treatments 
[49–51], TCP could be an effective approach in achiev-
ing tobacco cessation among disadvantaged tobacco 
users in Sweden.
Introducing TCP as an intervention model for tobacco 
cessation could be a means for implementing the national 
guidelines for disease prevention and supporting PHC 
to integrate health promotion into its daily activities. 
Better support from PHC staff in tobacco cessation 
could lead to more successful quit attempts and health 
improvements in the population. TCP may also help to 
reduce health inequalities by targeting disadvantaged 
groups who have a higher prevalence of tobacco use and 
related health problems compared to the general popu-
lation. However, before TCP can be implemented, more 
research is needed to further develop the content and 
the design of such a prescription. The effectiveness and 
cost-effectiveness of TCP should also be evaluated in 
comparison with current tobacco cessation strategies to 
determine whether or not its implementation would be 
an efficient allocation of society’s limited resources. Such 
an intervention study is currently under development.
A possible limitation to the study was that most of 
the interviews were conducted in Swedish when nei-
ther the interviewer, nor some of the participants were 
native Swedish speakers. A language barrier may thus 
have been introduced in the communication between 
the interviewer and the respondents, as well as in the 
interpretation of data [52]. However, the understand-
ing was enhanced through enquiries, audio-recording of 
the interviews and validation of the materials by a native 
Swedish speaker. In addition, social and cultural differ-
ences between the interviewer and the participants (e.g. 
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socioeconomic status, nationality, age, gender) may have 
influenced the data collected [52]. The public health 
background of the researchers performing the analysis 
may also have influenced the manner in which the mate-
rial was coded and categorised. Another limitation of the 
study was that only the manifest content of the interview 
transcripts was considered in the analysis. This is a dis-
advantage of using a conventional approach to content 
analysis. However, this approach can be useful in concept 
development or model building [53] which was closely 
related to the aim of this study and therefore considered 
appropriate. Further, it should be noted that the findings 
from this study are based on the views of 32 participants. 
Although the credibility of the findings was enhanced 
by including a diverse sample of participants, represent-
ing different ages, sexes and respondent categories, there 
was only one male healthcare provider in the sample. 
Overall, fewer male providers were asked whether they 
wanted to participate, as predominantly female nurses 
were, or felt like they were, responsible for tobacco ces-
sation at the PHC centres that were involved in the study. 
A prescription approach to tobacco cessation treatment 
could be relevant in other countries as well, for example 
where physical activity or other lifestyle interventions are 
already being prescribed. However, the approach would 
have to be modified to the context in which it is intended 
to be used.
Conclusions
A TCP tool was perceived to be useful for both clients 
and providers, potentially facilitating a structured and 
effective approach to tobacco cessation in PHC, target-
ing disadvantaged groups. More research is needed to 
develop the prescription and investigate its effectiveness 
and cost-effectiveness compared to current strategies for 
tobacco cessation in a PHC setting.
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Appendix 1: Interview guide for experts
1. What is [Lifestyle intervention X] on prescription?
a. How was it developed?
b. What is its purpose? Who is the target group?
c.  What does the prescription look like?/What does 
it contain?
•  Why? (How was the content determined?)
•  What scientific evidence is the content based 
on?
d. Who is involved in the prescription process?
•  How motivated are those in prescribing [Life-
style intervention X] on prescription?
e. Are we talking about a paper or electronic pre-
scription?
•  What effect do you think that the mode of 
administration has?
2. What are the enabling factors for [Lifestyle interven-
tion X] on prescription to work as intended?
3. What are the barriers for [Lifestyle intervention X] 




4. What have you learned from your experiences with 
[Lifestyle intervention X] on prescription?
5. What do you think about the suggested Tobacco Ces-
sation on Prescription?
a. Do you think it would have an added value for 
tobacco cessation?
b. Do you think it would be helpful in reaching disad-
vantaged groups?
6. Do you have any further comments?
Appendix 2: Interview guide for clients
Personal details
1. How would you describe your health in relation to 
others of the same age?
Tobacco use
2. Describe your tobacco use (what, for how long, how 
much, when)
3. How do you feel about quitting?
a. Why? (motivation)
b. Do you have a strategy/plan for how to quit?
4. What support/help do you need in order to quit?
Experiences with tobacco cessation
5. Have you previously tried to quit?
a. How? Why?
b. What challenges did you experience during your 
quit attempt(s)? (e.g. weight gain)
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6. What do you know about available support for 
tobacco cessation (here in Stockholm)? Give exam-
ples.
7. Please describe any support you have sought to quit.
8. What experiences does your friends and family have 
from tobacco cessation that you know of? Results?
Tobacco Cessation on Prescription
Tobacco Cessation on Prescription means that your doc-
tor/nurse/physiotherapist or other healthcare provider 
could prescribe you something to support you in quitting 
your tobacco use.
9. If you could get a prescription for tobacco cessa-
tion…
a. What would you think about that?
b. What would the prescription say? Why?
c. What would it look like? Why?
10. Please describe how you think Tobacco Cessation 
on Prescription could support someone to quit their 
tobacco use.
a. Why? Why not?
b. What are the possible advantages of Tobacco Ces-
sation on Prescription?
c. What are the possible disadvantages of Tobacco 
Cessation on Prescription?
d. How do you think others would perceive Tobacco 
Cessation on Prescription? (attitudes)
11. When would you like healthcare providers to pre-
scribe tobacco cessation to you?




13. Do you have anything else you would like to add?
14. How did you perceive this interview?
Appendix 3: Interview guide for providers
Personal details
1. What is your role at this primary healthcare centre?
a. What is your highest education?
b. How long have you been working in primary care 
in Stockholm/this primary healthcare centre?
Tobacco use
2. Please describe your experiences and the experiences 
of friends and family with regard to tobacco use.
a. Did you/they wish to quit using tobacco? Why? 
How?
Experiences with tobacco cessation
3. What are your experiences with tobacco use and 
tobacco cessation among your patients?
a. Do you offer your patients support for tobacco 
cessation or do your patients ask you for support 
to quit their tobacco use?
b. How do you support them?
c. How do you think you could support your patients 
better?
d. What do you need to better support patients to 
quit? Give examples.
4. Please describe how you perceive their knowledge 
about tobacco cessation.
5. What support for tobacco cessation (here in Stock-
holm) do patients know of?
Tobacco Cessation on Prescription
Tobacco Cessation on Prescription means that you and 
other healthcare providers could prescribe something 
to your patients to support them to quit their tobacco 
use.
6. If you could prescribe tobacco cessation…
a. What would you think about that?
b. What would the prescription say? Why?
c. What would it look like? Why?
d. What would guidelines for the prescription look 
like? Why?
7. Please describe how you think Tobacco Cessation 
on Prescription could support patients to quit their 
tobacco use.
a. Why? Why not?
b. What are the possible advantages of Tobacco Ces-
sation on Prescription?
c. What are the possible disadvantages of Tobacco 
Cessation on Prescription?
d. How do you think patients would perceive 
Tobacco Cessation on Prescription? (attitudes)
8. Please describe how you think Tobacco Cessation on 
Prescription could help healthcare providers to sup-
port patients to quit their tobacco use.
a. Why? Why not?
b. What are the possible advantages of Tobacco 
Cessation on Prescription?
c. What are the possible disadvantages of Tobacco 
Cessation on Prescription?
d. How do you think your colleagues would perceive 
Tobacco Cessation on Prescription? (attitudes)
e. What time, budget and infrastructure would be 
needed to implement Tobacco Cessation on Pre-
scription?
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9. Who would you prescribe tobacco cessation to?
10. Please describe what you expect the compliance to 
Tobacco Cessation on Prescription would be.
11. Who do you think should be responsible for pre-
scribing Tobacco Cessation on Prescription? Give 
examples.
Further comments
12. Do you have anything else you would like to add?
13. How did you perceive this interview?
Received: 29 September 2015   Accepted: 22 February 2016
References
 1. World Health Organization: WHO Report on the Global TOBACCO Epi-
demic, 2008 The MPOWER Package. 2008.
 2. National Board of Health and Welfare. Register data on the harmful 
effects of tobacco use; 2014.
 3. Galanti MR, Gilljam H, Post A, Eriksson B. Tobacco use in the county; 2011.
 4. U.S. Department of Health and Human Services. The health conse-
quences of smoking—50 years of progress a report of the surgeon 
general. Atlanta; 2014.
 5. Reinfeldt F, Larsson M. Government proposition 2007/08:110 A Renewed 
Public Health Policy. Swedish Government; 2007.
 6. National Board of Health and Welfare. National guidelines for disease 
prevention methods 2011. Tobacco use, alcohol consumption, physical 
inactivity and unhealthy dietary habits. Support for control and Manage-
ment; 2011.
 7. Hiscock R, Bauld L, Amos A, Fidler JA, Munafò M. Socioeconomic status 
and smoking: a review. Ann NY Acad Sci. 2012;1248:107–23.
 8. Roddy E, Antoniak M, Britton J, Molyneux A, Lewis S. Barriers and motiva-
tors to gaining access to smoking cessation services amongst deprived 
smokers–a qualitative study. BMC Health Serv Res. 2006;6:147.
 9. Bonevski B, Bryant J, Paul C. Encouraging smoking cessation among 
disadvantaged groups: a qualitative study of the financial aspects of ces-
sation. Drug Alcohol Rev. 2011;30:411–8.
 10. Walander A, Ålander S, Burström B. Social differences in healthcare utilisa-
tion. Stockholm; 2004.
 11. Osborne RH, Batterham RW, Elsworth GR, Hawkins M, Buchbinder R. The 
grounded psychometric development and initial validation of the Health 
Literacy Questionnaire (HLQ). BMC Public Health. 2013;13:658.
 12. Tomson T, Tomson G, Savage C. Educating health professionals for the 
challenges of the new century. Läkartidningen. 2012;32–33:1388–9.
 13. Nilsson Carlsson I, Sorsa R. Strong support among doctors to work with 
disease prevention. Läkartidningen. 2013;110:392–3.
 14. Professional Associations for Physical Activity. Physical activity in the 
prevention of treatment and disease. Swedish National Institute of Public 
Health; 2010.
 15. Kallings L. Physical activity on prescription : studies on physical activity 
level, adherence and cardiovascular risk factors. PhD thesis. Karolinska 
Institutet, Department of Neurobiology, Care Sciences and Society; 2008.
 16. Kallings L: Physical activity on prescription in scandinavia—experiences 
and recommendations. NHV Report 2010:12 R. Göteborg; 2010.
 17. Elley CR, Kerse N, Arroll B, Robinson E. Effectiveness of counselling 
patients on physical activity in general practice: cluster randomised 
controlled trial. BMJ. 2003;326:793.
 18. Riddoch C, Puig-Ribera A, Cooper A: Effectiveness of physical activity pro-
motion schemes in primary care: a review. Health Promotion Effective-
ness Review: Summary Bulletin 14; 1998.
 19. Sørensen J, Skovgaard T, Puggaard L. Exercise on prescription in general 
practice: a systematic review. Scand J Prim Heal Care. 2006;24:69–74.
 20. Patrick K, Sallis J, Calfas K. PACE (Patient-Centered Assessment and Coun-
seling for Exercise and Nutrition); 2003.
 21. National Health Service. Exercise referral systems: a national quality assur-
ance framework; 2001.
 22. Grandes G, Sanchez A, Sanchez-Pinilla RO, Torcal J, Montoya I, Lizarraga K, 
Serra J. Effectiveness of physical activity advice and prescription by physi-
cians in routine primary care: a cluster randomized trial. Arch Intern Med. 
2009;169:694–701.
 23. Swedish Institute of Public Health. PAP—individual based prescription of 
physical activity; 2011.
 24. Hjalmarson A, Attebring MF, Herlitz J. Difficult to implement tobacco use 
cessation in the regular care routine. Läkartidningen. 2012;109:1290–3.
 25. Elo S, Kyngäs H. The qualitative content analysis process. J Adv Nurs. 
2008;62:107–15.
 26. Robson C. Part III—Tactics: The methods of data collection. In: Real world 
research—a resource for social scientists and practitioner-researchers. 
2nd edn. Cornwall: Blackwell Publishing Limited; 2002.
 27. Elo S, Kaariainen M, Kanste O, Polkki T, Utriainen K, Kyngas H. Qualitative 
content analysis: a focus on trustworthiness. SAGE Open. 2014;4:1–10.
 28. Burström B, Walander A, Viberg I, Bruce D, Agerholm J, Ponce de Leon A. 
Proposal for socioeconomic index. Stockholm; 2013.
 29. Gaskell G. Individual and group interviewing. In: Bauer M, Gaskell G, edi-
tors. Qualitative researching with text, image and sound. London: Sage; 
2000. p. 38–56.
 30. Hsieh H-F, Shannon SE. Three approaches to qualitative content analysis. 
Qual Health Res. 2005;15:1277–88.
 31. Graneheim UH, Lundman B. Qualitative content analysis in nursing 
research: concepts, procedures and measures to achieve trustworthiness. 
Nurse Educ Today. 2004;24:105–12.
 32. Clark J. How to peer review a qualitative manuscript. In: Godlee F, Jeffer-
son T, editors. Peer review in health sciences. 2nd ed. London: BMJ Books; 
2003. p. 219–35.
 33. Christie B. Payment to help quit smoking “works”, says study. BMJ. 
2012;344:e3327.
 34. Zwar NA, Mendelsohn CP, Richmond RL. Supporting smoking cessation. 
BMJ. 2014;348:f7535.
 35. Baldwin AS, Rothman AJ, Hertel AW, Linde JA, Jeffery RW, Finch EA, Lando 
HA. Specifying the determinants of the initiation and maintenance of 
behavior change: an examination of self-efficacy, satisfaction, and smok-
ing cessation. Health Psychol. 2006;25:626–34.
 36. Chouinard M-C, Robichaud-Ekstrand S. Predictive value of the tran-
stheoretical model to smoking cessation in hospitalized patients with 
cardiovascular disease. Eur J Cardiovasc Prev Rehabil. 2007;14:51–8.
 37. Woodruff SI, Conway TL, Edwards CC. Sociodemographic and smoking-
related psychosocial predictors of smoking behavior change among high 
school smokers. Addict Behav. 2008;33:354–8.
 38. World Health Organization. Tobacco and inequities—guidance for 
addressing inequities in tobacco-related harm; 2014.
 39. Alberg AJ, Carpenter MJ. Enhancing the effectiveness of smoking ces-
sation interventions: a cancer prevention imperative. J Natl Cancer Inst. 
2012;104:260–2.
 40. Szatkowski L, Coleman T, McNeill A, Lewis S. The impact of the introduc-
tion of smoke-free legislation on prescribing of stop-smoking medica-
tions in England. Addiction. 2011;106:1827–34.
 41. Verbiest MEA, Chavannes NH, Crone MR, Nielen MMJ, Segaar D, Korevaar 
JC, Assendelft WJJ. An increase in primary care prescriptions of stop-
smoking medication as a result of health insurance coverage in the 
Netherlands: population based study. Addiction. 2013;108:2183–92.
 42. Romé A, Persson U, Ekdahl C, Gard G. Willingness to pay for health 
improvements of physical activity on prescription. Scand J Public Health. 
2010;38:151–9.
 43. Hébert ET, Caughy MO, Shuval K. Primary care providers’ perceptions of 
physical activity counselling in a clinical setting: a systematic review. Br J 
Sports Med. 2012;46:625–31.
 44. Persson G, Brorsson A, Ekvall Hansson E, Troein M, Strandberg EL. Physical 
activity on prescription (PAP) from the general practitioner’s perspec-
tive—a qualitative study. BMC Fam Pract. 2013;14:128.
 45. Josyula LK, Lyle RM. Barriers in the implementation of a physical activity 
intervention in primary care settings: lessons learned. Health Promot 
Pract. 2013;14:81–7.
Page 12 of 12Leppänen et al. BMC Res Notes  (2016) 9:151 
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
 46. Malmquist P, Pettersson S. Reimbursement models in primary care. Stock-
holm: The Swedish Association for Health Professionals; 2010.
 47. Jones F, Harris P, Waller H, Coggins A. Adherence to an exercise prescrip-
tion scheme: the role of expectations, self-efficacy, stage of change and 
psychological well-being. Br J Health Psychol. 2005;10(Pt 3):359–78.
 48. Romé Å, Persson U, Ekdahl C, Gard G. Costs and outcomes of an exer-
cise referral programme—a 1-year follow-up study. Eur J Physiother. 
2014;16:82–92.
 49. Safran DG, Kosinski M, Tarlov AR, Rogers WH, Taira DH, Lieberman N, 
Ware JE. The Primary Care Assessment Survey: tests of data quality and 
measurement performance. Med Care. 1998;36:728–39.
 50. Thom DH, Ribisl KM, Stewart AL, Luke DA. Further validation and reliability 
testing of the Trust in Physician Scale. The stanford trust study physicians. 
Med Care. 1999;37:510–7.
 51. Hall MA, Zheng B, Dugan E, Camacho F, Kidd KE, Mishra A, Balkrishnan R. 
Measuring patients’ trust in their primary care providers. Med Care Res 
Rev. 2002;59:293–318.
 52. Green J, Thorogood N. Qualitative methods for health research. 2nd ed. 
London: Sage Publications Limited; 2009.
 53. Lindkvist K. Approaches to textual analysis. In: Rosengren KE, editor. 
Advances in content analysis. Beverly Hills: Sage Publications Limited; 
1981. p. 23–41.
